title: More surprises lying ahead. The endocannabinoids keep us guessing.
abstract: The objective of this review is to point out some important facts that we don't know about endogenous cannabinoids - lipid-derived signaling molecules that activate CB1 cannabinoid receptors and play key roles in motivation, emotion and energy balance. The first endocannabinoid substance to be discovered, anandamide, was isolated from brain tissue in 1992. Research has shown that this molecule is a bona fide brain neurotransmitter involved in the regulation of stress responses and pain, but the molecular mechanisms that govern its formation and the neural pathways in which it is employed are still unknown. There is a general consensus that enzyme-mediated cleavage, catalyzed by fatty acid amide hydrolase (FAAH), terminates the biological actions of anandamide, but there are many reasons to believe that other as-yet-unidentified proteins are also involved in this process. We have made significant headway in understanding the second arrived in the endocannabinoid family, 2-arachidonoyl-sn-glycerol (2-AG), which was discovered three years after anandamide. Researchers have established some of the key molecular players involved in 2-AG formation and deactivation, localized them to specific synaptic components, and showed that their assembly into a multi-molecular protein complex (termed the '2-AG signalosome') allows 2-AG to act as a retrograde messenger at excitatory synapses of the brain. Basic questions that remain to be answered pertain to the exact molecular composition of the 2-AG signalosome, its regulation by neural activity and its potential role in the actions of drugs of abuse such as Δ(9)-THC and cocaine. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'.
authors: Department of Anatomy and Neurobiology, University of California, Irvine, CA 92697-1275, USA; Department of Pharmacology, University of California, Irvine, CA 92697-1275, USA; Department of Drug Discovery and Development, Istituto Italiano di Tecnologia, Genoa 16163, Italy; Department of Biological Chemistry, University of California, Irvine, CA 92697-1275, USA. Electronic address: piomelli@uci.edu.
authors: Daniele
authors: D
authors: Piomelli
mesh_terms: D000581:Amidohydrolases / Q000378:metabolism; D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D063388:Endocannabinoids / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D053284:Polyunsaturated Alkamides / Q000378:metabolism; D043882:Receptors, Cannabinoid / Q000235:genetics / Q000378:metabolism*; D019966:Substance-Related Disorders / Q000188:drug therapy / Q000378:metabolism; D000099252:Fatty Acid Amide Hydrolases
chemical_list: D000581:Amidohydrolases; D001095:Arachidonic Acids; D063388:Endocannabinoids; D053284:Polyunsaturated Alkamides; D043882:Receptors, Cannabinoid; D000099252:Fatty Acid Amide Hydrolases; C078814:anandamide
keywords: Anandamide; Cannabinoid receptor; Cocaine; Drugs of abuse; Endocannabinoid
references: J Neuroendocrinol. 2008 May;20 Suppl 1:10-4
references: 18426493
references: Nat Rev Neurosci. 2007 Oct;8(10):743-54
references: 17882252
references: Naunyn Schmiedebergs Arch Pharmacol. 2003 Nov;368(5):432-6
references: 14566450
references: PLoS One. 2012;7(12):e50968
references: 23236415
references: Mol Pharmacol. 2004 Nov;66(5):1260-4
references: 15272052
references: Nat Neurosci. 1999 Apr;2(4):358-63
references: 10204543
references: Proc Natl Acad Sci U S A. 1979 Jul;76(7):3238-41
references: 290999
references: Eur J Neurosci. 1999 Dec;11(12):4213-25
references: 10594647
references: Neuron. 2012 Oct 4;76(1):70-81
references: 23040807
references: Mol Psychiatry. 2013 Jul;18(7):813-23
references: 22688188
references: J Biol Chem. 1996 Jul 19;271(29):17287-95
references: 8663381
references: J Biol Chem. 2006 Sep 8;281(36):26465-72
references: 16818490
references: Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9371-6
references: 11470906
references: Biol Psychiatry. 2007 Nov 15;62(10):1103-10
references: 17511970
references: Nat Chem Biol. 2009 Jan;5(1):37-44
references: 19029917
references: J Biol Chem. 2008 Apr 4;283(14):9341-9
references: 18227059
references: Nature. 2005 Jun 23;435(7045):1108-12
references: 15973410
references: J Comp Neurol. 2008 Feb 1;506(4):604-15
references: 18067139
references: Curr Opin Investig Drugs. 2005 Jul;6(7):672-9
references: 16044662
references: PLoS One. 2013;8(4):e60040
references: 23573230
references: Science. 2002 Apr 26;296(5568):678-82
references: 11976437
references: Nat Neurosci. 2004 Jul;7(7):697-8
references: 15184902
references: Mol Pharmacol. 2011 Apr;79(4):786-92
references: 21233218
references: J Biol Chem. 2000 Oct 27;275(43):33744-9
references: 10931854
references: Science. 1997 Aug 22;277(5329):1094-7
references: 9262477
references: Nature. 1975 Dec 18;258(5536):577-80
references: 1207728
references: J Cell Biol. 2003 Nov 10;163(3):463-8
references: 14610053
references: Science. 1992 Dec 18;258(5090):1882-4
references: 1335165
references: Trends Endocrinol Metab. 2013 Jul;24(7):332-41
references: 23567058
references: Neuropharmacology. 2008 Jan;54(1):95-107
references: 17655884
references: Genomics. 1998 Jun 1;50(2):267-74
references: 9653654
references: Eur J Neurosci. 2004 Jul;20(2):441-58
references: 15233753
references: Prog Lipid Res. 1990;29(1):1-43
references: 2087478
references: J Biol Chem. 2010 Dec 17;285(51):39976-85
references: 20923771
references: Chem Biol. 2007 Dec;14(12):1347-56
references: 18096503
references: Prog Lipid Res. 2010 Oct;49(4):299-315
references: 20152858
references: Science. 1973 Mar 9;179(4077):1011-4
references: 4687585
references: Nature. 1996 Nov 7;384(6604):83-7
references: 8900284
references: Mol Pharmacol. 1988 Nov;34(5):605-13
references: 2848184
references: J Neurosci. 1999 Jun 1;19(11):4544-58
references: 10341254
references: Pain. 2013 Mar;154(3):350-360
references: 23218523
references: Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18620-5
references: 16352709
references: Nature. 1997 Aug 21;388(6644):773-8
references: 9285589
references: Adv Prostaglandin Thromboxane Leukot Res. 1995;23:163-5
references: 7732825
references: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5802-7
references: 10318965
references: Nat Neurosci. 2010 Oct;13(10):1265-70
references: 20852626
references: Biochem Pharmacol. 1995 Jun 29;50(1):83-90
references: 7605349
references: Nat Neurosci. 2011 Nov 06;14(12):1542-7
references: 22057189
references: Nature. 1988 Jul 21;334(6179):268-70
references: 3398923
references: Eur J Neurosci. 2009 May;29(10):1964-78
references: 19453631
references: Neuropsychopharmacology. 2013 Mar;38(4):574-84
references: 23169348
references: Proc Natl Acad Sci U S A. 1976 Oct;73(10):3729-33
references: 185626
references: Science. 1992 Dec 18;258(5090):1946-9
references: 1470919
references: J Biol Chem. 1995 Oct 6;270(40):23823-7
references: 7559559
references: Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13345-50
references: 16938887
references: Biochim Biophys Acta. 1995 Aug 3;1257(3):249-56
references: 7647100
references: Nat Neurosci. 2011 Nov 20;15(1):64-9
references: 22101642
references: J Mol Neurosci. 2000 Jun;14(3):123-35
references: 10984188
references: Nat Neurosci. 2010 Aug;13(8):951-7
references: 20657592
references: Nat Med. 2003 Jan;9(1):76-81
references: 12461523
references: Nature. 1994 Dec 15;372(6507):686-91
references: 7990962
references: Cell Metab. 2012 Mar 7;15(3):299-310
references: 22405068
references: Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10819-24
references: 12136125
references: FEBS Lett. 1995 Nov 13;375(1-2):117-20
references: 7498458
references: Annu Rev Neurosci. 2012;35:529-58
references: 22524785
references: Neuroreport. 2000 Apr 27;11(6):1231-5
references: 10817598
references: J Neurosci. 1997 Feb 15;17(4):1226-42
references: 9006968
references: Biochim Biophys Acta. 2006 Dec;1758(12):2133-8
references: 17064658
references: J Biol Chem. 1995 Mar 17;270(11):6030-5
references: 7890734
references: Eur J Pharmacol. 2001 Aug 17;425(3):189-96
references: 11513837
references: Nat Neurosci. 2010 Sep;13(9):1113-9
references: 20729846
references: Biochem Biophys Res Commun. 1995 Oct 4;215(1):89-97
references: 7575630
references: Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1500-5
references: 23297193
references: Pharmacol Ther. 2008 Oct;120(1):71-80
references: 18700152
references: Proc Natl Acad Sci U S A. 2010 May 18;107(20):9406-11
references: 20439721
references: J Neurosci. 2011 Mar 2;31(9):3243-8
references: 21368036
references: J Neurochem. 1992 Mar;58(3):1130-9
references: 1737988
references: FEBS J. 2013 May;280(9):1874-94
references: 23425575
references: Acta Pharmacol Toxicol (Copenh). 1973;33(5):377-84
references: 4801083
references: J Neurosci. 2006 May 24;26(21):5628-37
references: 16723519
references: J Neurosci. 1996 Jun 15;16(12):3934-42
references: 8656287
references: Sci Rep. 2013;3:1035
references: 23301156
references: Neuropsychopharmacology. 2012 Oct;37(11):2416-27
references: 22763622
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Sep 15;877(26):2755-67
references: 19171504
references: Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8756-61
references: 15138300
references: Nat Commun. 2012;3:1080
references: 23011134
references: Nature. 1990 Aug 9;346(6284):561-4
references: 2165569
references: Mol Pharmacol. 2007 Sep;72(3):612-21
references: 17584991